Skip to Content

APO 046 125 (Divalproex sodium delayed-release 125 mg)

Pill imprint APO 046 125 has been identified as Divalproex sodium delayed-release 125 mg.

Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substance Act (CSA).

Divalproex sodium delayed-release 125 mg APO 046 125
Discount Card Promo
Divalproex sodium delayed-release
APO 046 125
125 mg
12.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Apotex Corp.
National Drug Code (NDC):
Inactive Ingredients:
methacrylic acid - ethyl acrylate copolymer (1:1) type a
microcrystalline cellulose
polyethylene glycol
magnesium silicate
titanium dioxide
triethyl citrate
hydroxypropyl cellulose

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.